🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will enroll patients who received neoadjuvant therapy for TNBC p...
Status
Active Not Recruiting
Location
Korea University, Guro hospital
Start Date
2019-01-15
Trial ID
NCT03756298
Treatments Being Tested
This is a phase II study aiming at evaluating capecitabine prospectively at...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-02-14
Trial ID
NCT06105684
Treatments Being Tested
The purpose of this study is to see if capecitabine can be taken safely wit...
Status
Completed
Location
University of Michigan Health System
Start Date
2016-01-06
Trial ID
NCT02650752
Treatments Being Tested
This is an open, multi-cohort, multi-center, exploratory and phase II clini...
Status
Unknown
Location
Jiangsu Cancer Hospital
Start Date
2021-12-01
Trial ID
NCT05262335
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
This randomized phase II trial studies how well trametinib or combination c...
Status
Completed
Location
Alaska Breast Care and Surgery LLC
Start Date
2014-02
Trial ID
NCT02042443
Treatments Being Tested
This 2 arm study will assess the efficacy and safety of intermittent oral X...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069108
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
RATIONALE: Drugs used in chemotherapy, such as capecitabine and irinotecan ...
Status
Unknown
Location
Davood Vafai, MD, Medical Offices, Incorporated
Start Date
2009-07
Trial ID
NCT00967655
The purpose of this study is to compare the survival and toxicity of TPC (T...
Status
Completed
Location
SunYat-senU
Start Date
2016-10-20
Trial ID
NCT02940925
Treatments Being Tested